We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

1 hedge funds and large institutions have $52K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 297 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 298 → 1 (-297)

100% less funds holding in top 10

Funds holding in top 10: 47 → 0 (-47)

100% less capital invested

Capital invested by funds: $10.8B → $52K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 297

Holders
1
Holders Change
-297
Holders Change %
-99.66%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-47
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
297
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
-$950M
2
PCM
Pentwater Capital Management
Florida
-$652M
3
State Street
State Street
Massachusetts
-$376M
4
YCMGA
York Capital Management Global Advisors
New York
-$327M
5
BIT
BlackRock Institutional Trust
California
-$317M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
126
Metropolitan Life Insurance Company (MetLife)
New York
– -$10.1M -58,717 Closed
Allianz Asset Management
127
Allianz Asset Management
Germany
– -$10.1M -58,284 Closed
BlackRock
128
BlackRock
New York
– -$9.73M -56,301 Closed
TPSF
129
Texas Permanent School Fund
Texas
– -$9.19M -53,193 Closed
Comerica Bank
130
Comerica Bank
Texas
– -$9.07M -52,487 Closed
BCM
131
Brown Capital Management
Maryland
– -$8.79M -50,848 Closed
KC
132
Kellner Capital
New York
– -$8.78M -50,800 Closed
AllianceBernstein
133
AllianceBernstein
Tennessee
– -$8.75M -50,641 Closed
LP
134
LMR Partners
United Kingdom
– -$8.57M -49,575 Closed
PAM
135
Panagora Asset Management
Massachusetts
– -$8.39M -48,531 Closed
State of Wisconsin Investment Board
136
State of Wisconsin Investment Board
Wisconsin
– -$8.32M -48,150 Closed
Citigroup
137
Citigroup
New York
– -$8.13M -47,030 Closed
UBS Group
138
UBS Group
Switzerland
– -$7.94M -45,952 Closed
Prudential Financial
139
Prudential Financial
New Jersey
– -$7.8M -45,166 Closed
GLAM
140
Gardner Lewis Asset Management
Pennsylvania
– -$7.66M -44,340 Closed
SCM
141
Stevens Capital Management
Pennsylvania
– -$7.25M -41,955 Closed
Susquehanna International Group
142
Susquehanna International Group
Pennsylvania
– -$7.19M -41,580 Closed
MOACM
143
Mutual of America Capital Management
New York
– -$7.17M -41,491 Closed
Nisa Investment Advisors
144
Nisa Investment Advisors
Missouri
– -$7.05M -40,800 Closed
PPA
145
Parametric Portfolio Associates
Washington
– -$6.57M -38,005 Closed
DekaBank Deutsche Girozentrale
146
DekaBank Deutsche Girozentrale
Germany
– -$6.41M -37,080 Closed
Federated Hermes
147
Federated Hermes
Pennsylvania
– -$6.41M -37,070 Closed
LCS
148
Levin Capital Strategies
New York
– -$6.38M -36,900 Closed
AAMU
149
Amundi Asset Management US
Massachusetts
– -$6.35M -36,771 Closed
SCI
150
Seneca Capital Investments
New York
– -$6.31M -36,500 Closed
4 5
6
7 8

SLXP Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2015, worth a combined $52K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 297 funds closed out of SLXP and 0 opened new positions — a net loss of 297 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Paulson & Co, exiting entirely with an estimated $950M sold.

  • 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2015, down from 298 in Q1 2015.
  • Funds reported $52K of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2015 and 297 closed out, a net change of -297 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2015 was Paulson & Co, an estimated $950M sold.

Based on aggregated 13F filings for Q2 2015.